Neurocrine Biosciences Inc (NBIX) valuation · P/E 20, rev $2.86B
Neurocrine Biosciences Inc (NBIX) P/E 20, rev $2.86B.
| Metric | Value |
|---|---|
| P/E | 20 |
| Market cap | $13.21B |
| Revenue | $2.86B |
| P/S | 4.6 |
NBIX valuation FAQ
What is NBIX's P/E ratio?
Neurocrine Biosciences Inc (NBIX) trailing P/E is 20 on the latest cached fundamentals snapshot.
What is NBIX's market cap?
Neurocrine Biosciences Inc (NBIX) market cap is $13.21B on the latest cached fundamentals snapshot.
What is NBIX's latest revenue?
Latest cached Neurocrine Biosciences Inc (NBIX) revenue was $2.86B. Statements: https://lician.com/financials/nbix
What is NBIX's price-to-sales ratio?
Neurocrine Biosciences Inc (NBIX) price-to-sales (P/S) is 4.6, cached market cap $13.21B divided by revenue $2.86B.
How many NBIX valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Neurocrine Biosciences Inc (NBIX): P/E, Market cap, Revenue, and P/S.
Where is NBIX valuation listed?
Cached valuation multiples for Neurocrine Biosciences Inc (NBIX) are listed at https://lician.com/valuation/nbix.
Not investment advice. Cached rows, not a live tape.